Literature DB >> 22975006

Evolution of neurodegeneration.

Mark R Cookson1.   

Abstract

A number of neurodegenerative diseases principally affect humans as they age and are characterized by the loss of specific groups of neurons in different brain regions. Although these disorders are generally sporadic, it is now clear that many of them have a substantial genetic component. As genes are the raw material with which evolution works, we might benefit from understanding these genes in an evolutionary framework. Here, I will discuss how we can understand whether evolution has shaped genes involved in neurodegeneration and the implications for practical issues, such as our choice of model systems for studying these diseases, and more theoretical concerns, such as the level of selection against these phenotypes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22975006      PMCID: PMC4662249          DOI: 10.1016/j.cub.2012.07.008

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  100 in total

Review 1.  Milestones in Parkinson's disease--clinical and pathologic features.

Authors:  Glenda Halliday; Andrew Lees; Matthew Stern
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 2.  Milestones in PD genetics.

Authors:  Thomas Gasser; John Hardy; Yoshikuni Mizuno
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 3.  Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens.

Authors:  J Hardy; A Pittman; A Myers; K Gwinn-Hardy; H C Fung; R de Silva; M Hutton; J Duckworth
Journal:  Biochem Soc Trans       Date:  2005-08       Impact factor: 5.407

4.  Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2.

Authors:  João Paulo L Daher; Olga Pletnikova; Saskia Biskup; Alessandra Musso; Sandra Gellhaar; Dagmar Galter; Juan C Troncoso; Michael K Lee; Ted M Dawson; Valina L Dawson; Darren J Moore
Journal:  Hum Mol Genet       Date:  2012-02-21       Impact factor: 6.150

5.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.

Authors:  Günter U Höglinger; Nadine M Melhem; Dennis W Dickson; Patrick M A Sleiman; Li-San Wang; Lambertus Klei; Rosa Rademakers; Rohan de Silva; Irene Litvan; David E Riley; John C van Swieten; Peter Heutink; Zbigniew K Wszolek; Ryan J Uitti; Jana Vandrovcova; Howard I Hurtig; Rachel G Gross; Walter Maetzler; Stefano Goldwurm; Eduardo Tolosa; Barbara Borroni; Pau Pastor; Laura B Cantwell; Mi Ryung Han; Allissa Dillman; Marcel P van der Brug; J Raphael Gibbs; Mark R Cookson; Dena G Hernandez; Andrew B Singleton; Matthew J Farrer; Chang-En Yu; Lawrence I Golbe; Tamas Revesz; John Hardy; Andrew J Lees; Bernie Devlin; Hakon Hakonarson; Ulrich Müller; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

Review 6.  Targeting Abeta and tau in Alzheimer's disease, an early interim report.

Authors:  Todd E Golde; Leonard Petrucelli; Jada Lewis
Journal:  Exp Neurol       Date:  2009-08-27       Impact factor: 5.330

Review 7.  The Roco protein family: a functional perspective.

Authors:  Ignacio Marín; Wouter N van Egmond; Peter J M van Haastert
Journal:  FASEB J       Date:  2008-06-03       Impact factor: 5.191

Review 8.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

9.  Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Authors:  Nathan Pankratz; Gary W Beecham; Anita L DeStefano; Ted M Dawson; Kimberly F Doheny; Stewart A Factor; Taye H Hamza; Albert Y Hung; Bradley T Hyman; Adrian J Ivinson; Dmitri Krainc; Jeanne C Latourelle; Lorraine N Clark; Karen Marder; Eden R Martin; Richard Mayeux; Owen A Ross; Clemens R Scherzer; David K Simon; Caroline Tanner; Jeffery M Vance; Zbigniew K Wszolek; Cyrus P Zabetian; Richard H Myers; Haydeh Payami; William K Scott; Tatiana Foroud
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

10.  Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

Authors:  Byoung Dae Lee; Joo-Ho Shin; Jackalina VanKampen; Leonard Petrucelli; Andrew B West; Han Seok Ko; Yun-Il Lee; Kathleen A Maguire-Zeiss; William J Bowers; Howard J Federoff; Valina L Dawson; Ted M Dawson
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

View more
  7 in total

1.  Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson's Disease.

Authors:  Asya Ozkizilcik; Aruna Sharma; Dafin F Muresanu; José V Lafuente; Z Ryan Tian; Ranjana Patnaik; Herbert Mössler; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 2.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

3.  A mitochondrial location for haemoglobins--dynamic distribution in ageing and Parkinson's disease.

Authors:  Freya Shephard; Oliver Greville-Heygate; Oliver Marsh; Susan Anderson; Lisa Chakrabarti
Journal:  Mitochondrion       Date:  2013-12-10       Impact factor: 4.160

4.  Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage.

Authors:  Zhongbo Chen; David Zhang; Regina H Reynolds; Emil K Gustavsson; Sonia García-Ruiz; Karishma D'Sa; Aine Fairbrother-Browne; Jana Vandrovcova; John Hardy; Henry Houlden; Sarah A Gagliano Taliun; Juan Botía; Mina Ryten
Journal:  Nat Commun       Date:  2021-04-06       Impact factor: 14.919

5.  Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.

Authors:  James M Gruschus
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

6.  An evolutionary roadmap to the microtubule-associated protein MAP Tau.

Authors:  Frederik Sündermann; Maria-Pilar Fernandez; Reginald O Morgan
Journal:  BMC Genomics       Date:  2016-03-31       Impact factor: 3.969

7.  Hominin-specific regulatory elements selectively emerged in oligodendrocytes and are disrupted in autism patients.

Authors:  Bas Castelijns; Mirna L Baak; Ilia S Timpanaro; Caroline R M Wiggers; Marit W Vermunt; Peng Shang; Ivanela Kondova; Geert Geeven; Valerio Bianchi; Wouter de Laat; Niels Geijsen; Menno P Creyghton
Journal:  Nat Commun       Date:  2020-01-16       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.